RELUGOLIX | RELUGOLIX | ATC H01CC54
HORMONES TREATMENT OF PROSTATE CANCER A GONADOTROPIN-RELEASING HORMONE (GNRH) RECEPTOR ANTAGONIST | ORAL | Cmax 344.7 NANOMOLAR Tmax 2.25 HOUR F 12 PERCENT PPB 69.5 PERCENT Cl 29.4 LITER / HOUR HT 60.8 HOUR SOLUBILITY 0.04 MILLIGRAM PER MILLILITER IN WATER | GONADOTROPIN-RELEASING HORMONE (GNRH) RECEPTOR | Unknown - more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |